ROME (ITALPRESS) – Ninety years after Stein and Leventhal’s 1935 study on Polycystic Ovary Syndrome (PCOS), a condition that affects between 5 percent and 18 percent of women of childbearing age and often causes infertility, at the initiative of Senator Marco Scurria (Fdl), the EGOI-PCOS Scientific Association is organizing a series of institutional and medical-scientific training events to be promoted in 2025, a year dedicated to raising awareness and understanding of this still little-known condition.To open the series of initiatives, the institutional conference-Round Table that took place at the Senate of the Republic, in Sala Zuccari.An opportunity for dialogue, direct confrontation and greater awareness on the management of the syndrome.The Round Table also included a space for interventions and questions from participants affected by the pathology and present in the room. “The International Scientific Association EGOI-PCOS is focusing its efforts on a crucial aspect of this pathology, namely the metabolic origin, so much so that it has renamed it Endocrine-Metabolic Syndrome, whose signs and symptoms: insulin resistance, hirsutism, obesity, acne, depression, anxiety are so diverse that diagnosis is often complex. On the other hand, we have the multifollicular ovary, which is typical of adolescent girls and usually evolves physiologically with age”: says Professor Vittorio Unfer, gynecologist, researcher and co-President of EGOI-PCOS who continues: “This new classification, which represents an outgrowth of the classification promoted by the ESHRE, must lay the groundwork for developing a personalized treatment pathway for patients, including modifications in lifestyle and eating habits, and encouraging the choice of appropriate therapies, whether pharmacological or nonpharmacological.””One point of attention,” Unfer adds, “is the use of the contraceptive pill, a treatment mistakenly believed to be the gold standard of the condition but which, when speaking of Endocrine Metabolic Syndrome, can cause significant side effects such as altered body weight and cardiovascular disorders, to which these patients are already predisposed. He concludes, “The meeting aims to create a new awareness of Polycystic Ovary Syndrome in line with recent findings for a multidisciplinary and innovative approach.”
– photo spf/Italpress -(ITALPRESS).
